2 completed, 1 active not recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Neoplasms,Colorectal: new trials by email Literature Review of Neoplasms,Colorectal trials Research Report on Neoplasms,Colorectal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ESG401 in Adults With Solid Tumors ESG401 - Neoplasms, Breast, Neoplasms, Lung | Phase 1 / Phase 2 | Completed | Shanghai Escugen Biotechnology Co., Ltd | 156 | 2021-09-14 | 2025-09-12 |
| 9-ING-41 in Patients With Advanced Cancers 9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer | Phase 2 | Active not recruiting | Actuate Therapeutics Inc. | 350 | 2019-01-04 | 2026-04-03 |
| A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer cancer stem cell vaccine - Neoplasms,Colorectal | Phase 1 / Phase 2 | Completed | Fuda Cancer Hospital, Guangzhou | 40 | 2014-06-01 | 2019-09-12 |
Colorectal Neoplasms (3) · Breast Neoplasms (2) · Lung Neoplasms (2) · Bone Neoplasms (1) · Glioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Kidney Neoplasms (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphoma, Non-Hodgkin (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3) · Breast Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Lung Diseases (2)
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · Albumin-Bound Paclitaxel (1) · Carboplatin (1) · Doxorubicin (1) · Gemcitabine (1) · Irinotecan (1) · Lomustine (1) · Paclitaxel (1) · Taxes (1) · liposomal doxorubicin (1)
Actuate Therapeutics Inc. (1) · Fuda Cancer Hospital, Guangzhou (1) · Shanghai Escugen Biotechnology Co., Ltd (1)
China (2) · Belgium (1) · Canada (1) · France (1) · Netherlands (1) · Portugal (1) · Spain (1) · United States (1)
Fei Ma (1)
PMID 22473314, PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 35815408, PMID 39216478, PMID 40359710, PMID 41981308